A FLEXIBLE SENSITIVITY ANALYSIS APPROACH FOR UNMEASURED CONFOUNDING WITH MULTIPLE TREATMENTS AND A BINARY OUTCOME WITH APPLICATION TO SEER-MEDICARE LUNG CANCER DATA

被引:0
|
作者
Hu, Liangyuan [1 ]
Zou, Jungang [2 ]
Gu, Chenyang [3 ]
Ji, Jiayi [4 ]
Lopez, Michael [5 ]
Kale, Minal [6 ]
机构
[1] Rutgers State Univ, Dept Biostat & Epidemiol, New Brunswick, NJ 08854 USA
[2] Columbia Univ, Dept Biostat, New York, NY 10027 USA
[3] Brown Univ, Dept Biostat, Providence, RI 02912 USA
[4] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA
[5] Skidmore Coll, Dept Math, Saratoga Springs, NY 12866 USA
[6] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA
来源
ANNALS OF APPLIED STATISTICS | 2022年 / 16卷 / 02期
关键词
Causal inference; ignorability assumption; observational data; Bayesian inference; nested multiple imputation; IMPUTATION; MODEL;
D O I
10.1214/21-AOAS1530
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
In the absence of a randomized experiment, a key assumption for drawing causal inference about treatment effects is the ignorable treatment assignment. Violations of the ignorability assumption may lead to biased treatment effect estimates. Sensitivity analysis helps gauge how causal conclusions will be altered in response to the potential magnitude of departure from the ignorability assumption. However, sensitivity analysis approaches for unmeasured confounding in the context of multiple treatments and binary outcomes are scarce. We propose a flexible Monte Carlo sensitivity analysis approach for causal inference in such settings. We first derive the general form of the bias introduced by unmeasured confounding, with emphasis on theoretical properties uniquely relevant to multiple treatments. We then propose methods to encode the impact of unmeasured confounding on potential outcomes and adjust the estimates of causal effects in which the presumed unmeasured confounding is removed. Our proposed methods embed nested multiple imputation within the Bayesian framework, which allow for seamless integration of the uncertainty about the values of the sensitivity parameters and the sampling variability as well as use of the Bayesian Additive Regression Trees for modeling flexibility. Expansive simulations validate our methods and gain insight into sensitivity analysis with multiple treatments. We use the SEER-Medicare data to demonstrate sensitivity analysis using three treatments for early stage nonsmall cell lung cancer. The methods developed in this work are readily available in the R package SAMTx.
引用
收藏
页码:1014 / 1037
页数:24
相关论文
共 50 条
  • [31] Adjuvant Chemotherapy for Stage II Right- and Left-Sided Colon Cancer: Analysis of SEER-Medicare Data
    Weiss, Jennifer M.
    Schumacher, Jessica R.
    Allen, Glenn O.
    Neuman, Heather B.
    O'Connor, Erin S.
    LoConte, Noelle K.
    Smith, Maureen A.
    GASTROENTEROLOGY, 2013, 144 (05) : S587 - S587
  • [32] Risk Factors for Venous Thromboembolism in Metastatic Colon Cancer Patients in the Contemporary Treatment Era: A SEER-Medicare Data Analysis
    Pulluri, Bhargavi
    Littenberg, Benjamin
    Lal, Inder
    Holmes, Chris E.
    Ades, Steven
    BLOOD, 2016, 128 (22)
  • [33] Medical cost analysis: Application to colorectal cancer data from the SEER Medicare database
    Bang, H
    CONTEMPORARY CLINICAL TRIALS, 2005, 26 (05) : 586 - 597
  • [34] Utility of surveillance imaging in stage III non-small cell lung cancer (NSCLC) patients: A SEER-Medicare analysis
    Thakur, Manish K.
    Ruterbusch, Julie
    Schwartz, Ann G.
    Beebe-Dimmer, Jennifer Lynn
    Holowatyj, Andreana N.
    Wozniak, Antoinette J.
    Gadgeel, Shirish M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] Determinants of chemotherapy administration and effects of chemotherapy on survival in elderly patients with small cell lung cancer (SCLC): A SEER-Medicare analysis
    Caprario, L. C.
    Kent, D. M.
    Trikalinos, T. A.
    Strauss, G. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Comparison of Wedge Versus Lobar Resection for Stage 1 Non-Small Cell Lung Cancer: A SEER-Medicare Analysis
    Tuminello, Stephanie
    Wolf, Andrea
    Taioli, Emanuela
    Flores, Raja
    ANNALS OF THORACIC SURGERY, 2018, 106 (04): : 1260 - +
  • [37] EVALUATION OF SURVIVAL OUTCOMES OF POST-FRONTLINE ANTI-MYELOMA TREATMENTS IN MULTIPLE MYELOMA PATIENTS BASED ON DATA FROM SEER-MEDICARE DATABASE
    Nooka, A.
    Voorhees, P.
    Kumar, S.
    Mehra, M.
    Lam, A.
    Slavcev, m
    Ukropec, J.
    Dasgupta, A.
    VALUE IN HEALTH, 2017, 20 (05) : A214 - A214
  • [38] Do Physician Patient Sharing Networks Impact Disparities in Access to Multidisciplinary Cancer Consultation for EarlyStage Lung Cancer? A SEER-Medicare Network Analysis
    Liu, Y. C.
    Kapadia, N. S.
    Schmidt, R. O.
    Moen, E. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S126 - S126
  • [39] Ethnic Disparities in Gastric Cancer Presentation and Screening Practice in the United States: An Analysis of 1997-2010 SEER-Medicare Data
    Florea, A.
    Brown, H. E.
    Harris, R. B.
    Oren, E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (03) : 356 - 356
  • [40] PHYSICIAN REFERRAL PATTERNS AMONG ELDERLY PATIENTS WITH STAGE IV PROSTATE CANCER (PCA): AN ANALYSIS USING SEER-MEDICARE DATA
    Onukwugha, E. E.
    Mullins, C. D.
    Seal, B.
    Hussain, A.
    VALUE IN HEALTH, 2009, 12 (03) : A54 - A55